世界のフォン・ヒッペル-リンドウ病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Von Hippel-Lindau Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5380 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、フォン・ヒッペル-リンドウ病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRIスキャン、CTスキャン、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・フォン・ヒッペル-リンドウ病治療の市場動向 ・企業の競争状況、市場シェア ・フォン・ヒッペル-リンドウ病治療の種類別市場規模と予測2016-2027（MRIスキャン、CTスキャン、その他） ・フォン・ヒッペル-リンドウ病治療の用途別市場規模と予測2016-2027（病院、診療所、診断センター、その他） ・フォン・ヒッペル-リンドウ病治療の北米市場規模2016-2027（アメリカ、カナダ） ・フォン・ヒッペル-リンドウ病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・フォン・ヒッペル-リンドウ病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・フォン・ヒッペル-リンドウ病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・フォン・ヒッペル-リンドウ病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Bedford Laboratories、DNAtrix, Inc.、Astellas US Holding, Inc.、Advantagene, Inc、Burzynski Research Institute, Inc.、Cellectar Biosciences, Inc.、Direct Therapeutics, Inc.） ・結論

Von Hippel-Lindau is a rare autosomal dominant genetic disease. Its causative gene is located on chromosome 3P25-P26. The basic lesion is hemangioblastoma. The clinical feature is hemangioblastoma that occurs in the nervous system or the retina, Clear cell carcinoma of the kidney, pheochromocytoma, and multiple cysts or tumors of the liver, kidney, pancreas, and epididymis.

Market Analysis and Insights: Global Von Hippel-Lindau Treatment Market
The global Von Hippel-Lindau Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Von Hippel-Lindau Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Von Hippel-Lindau Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Von Hippel-Lindau Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Von Hippel-Lindau Treatment market.

Global Von Hippel-Lindau Treatment Scope and Market Size
Von Hippel-Lindau Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Von Hippel-Lindau Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MRI Scan
CT Scan
Others

Segment by Application
Hospitals
Clinics
Diagnostic Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly and Company
Bedford Laboratories
DNAtrix, Inc.
Astellas US Holding, Inc.
Advantagene, Inc
Burzynski Research Institute, Inc.
Cellectar Biosciences, Inc.
Direct Therapeutics, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Von Hippel-Lindau Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MRI Scan
1.2.3 CT Scan
1.2.4 Others
1.3 Market by Application
1.3.1 Global Von Hippel-Lindau Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Von Hippel-Lindau Treatment Market Perspective (2016-2027)
2.2 Von Hippel-Lindau Treatment Growth Trends by Regions
2.2.1 Von Hippel-Lindau Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Von Hippel-Lindau Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Von Hippel-Lindau Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Von Hippel-Lindau Treatment Industry Dynamic
2.3.1 Von Hippel-Lindau Treatment Market Trends
2.3.2 Von Hippel-Lindau Treatment Market Drivers
2.3.3 Von Hippel-Lindau Treatment Market Challenges
2.3.4 Von Hippel-Lindau Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Von Hippel-Lindau Treatment Players by Revenue
3.1.1 Global Top Von Hippel-Lindau Treatment Players by Revenue (2016-2021)
3.1.2 Global Von Hippel-Lindau Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Von Hippel-Lindau Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Von Hippel-Lindau Treatment Revenue
3.4 Global Von Hippel-Lindau Treatment Market Concentration Ratio
3.4.1 Global Von Hippel-Lindau Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Von Hippel-Lindau Treatment Revenue in 2020
3.5 Von Hippel-Lindau Treatment Key Players Head office and Area Served
3.6 Key Players Von Hippel-Lindau Treatment Product Solution and Service
3.7 Date of Enter into Von Hippel-Lindau Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Von Hippel-Lindau Treatment Breakdown Data by Type
4.1 Global Von Hippel-Lindau Treatment Historic Market Size by Type (2016-2021)
4.2 Global Von Hippel-Lindau Treatment Forecasted Market Size by Type (2022-2027)

5 Von Hippel-Lindau Treatment Breakdown Data by Application
5.1 Global Von Hippel-Lindau Treatment Historic Market Size by Application (2016-2021)
5.2 Global Von Hippel-Lindau Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Von Hippel-Lindau Treatment Market Size (2016-2027)
6.2 North America Von Hippel-Lindau Treatment Market Size by Type
6.2.1 North America Von Hippel-Lindau Treatment Market Size by Type (2016-2021)
6.2.2 North America Von Hippel-Lindau Treatment Market Size by Type (2022-2027)
6.2.3 North America Von Hippel-Lindau Treatment Market Size by Type (2016-2027)
6.3 North America Von Hippel-Lindau Treatment Market Size by Application
6.3.1 North America Von Hippel-Lindau Treatment Market Size by Application (2016-2021)
6.3.2 North America Von Hippel-Lindau Treatment Market Size by Application (2022-2027)
6.3.3 North America Von Hippel-Lindau Treatment Market Size by Application (2016-2027)
6.4 North America Von Hippel-Lindau Treatment Market Size by Country
6.4.1 North America Von Hippel-Lindau Treatment Market Size by Country (2016-2021)
6.4.2 North America Von Hippel-Lindau Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Von Hippel-Lindau Treatment Market Size (2016-2027)
7.2 Europe Von Hippel-Lindau Treatment Market Size by Type
7.2.1 Europe Von Hippel-Lindau Treatment Market Size by Type (2016-2021)
7.2.2 Europe Von Hippel-Lindau Treatment Market Size by Type (2022-2027)
7.2.3 Europe Von Hippel-Lindau Treatment Market Size by Type (2016-2027)
7.3 Europe Von Hippel-Lindau Treatment Market Size by Application
7.3.1 Europe Von Hippel-Lindau Treatment Market Size by Application (2016-2021)
7.3.2 Europe Von Hippel-Lindau Treatment Market Size by Application (2022-2027)
7.3.3 Europe Von Hippel-Lindau Treatment Market Size by Application (2016-2027)
7.4 Europe Von Hippel-Lindau Treatment Market Size by Country
7.4.1 Europe Von Hippel-Lindau Treatment Market Size by Country (2016-2021)
7.4.2 Europe Von Hippel-Lindau Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Von Hippel-Lindau Treatment Market Size (2016-2027)
8.2 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type
8.2.1 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application
8.3.1 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Region
8.4.1 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Von Hippel-Lindau Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Von Hippel-Lindau Treatment Market Size (2016-2027)
9.2 Latin America Von Hippel-Lindau Treatment Market Size by Type
9.2.1 Latin America Von Hippel-Lindau Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Von Hippel-Lindau Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Von Hippel-Lindau Treatment Market Size by Type (2016-2027)
9.3 Latin America Von Hippel-Lindau Treatment Market Size by Application
9.3.1 Latin America Von Hippel-Lindau Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Von Hippel-Lindau Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Von Hippel-Lindau Treatment Market Size by Application (2016-2027)
9.4 Latin America Von Hippel-Lindau Treatment Market Size by Country
9.4.1 Latin America Von Hippel-Lindau Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Von Hippel-Lindau Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Von Hippel-Lindau Treatment Market Size (2016-2027)
10.2 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type
10.2.1 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application
10.3.1 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Country
10.4.1 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Von Hippel-Lindau Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Von Hippel-Lindau Treatment Introduction
11.1.4 Eli Lilly and Company Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Bedford Laboratories
11.2.1 Bedford Laboratories Company Details
11.2.2 Bedford Laboratories Business Overview
11.2.3 Bedford Laboratories Von Hippel-Lindau Treatment Introduction
11.2.4 Bedford Laboratories Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.2.5 Bedford Laboratories Recent Development
11.3 DNAtrix, Inc.
11.3.1 DNAtrix, Inc. Company Details
11.3.2 DNAtrix, Inc. Business Overview
11.3.3 DNAtrix, Inc. Von Hippel-Lindau Treatment Introduction
11.3.4 DNAtrix, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.3.5 DNAtrix, Inc. Recent Development
11.4 Astellas US Holding, Inc.
11.4.1 Astellas US Holding, Inc. Company Details
11.4.2 Astellas US Holding, Inc. Business Overview
11.4.3 Astellas US Holding, Inc. Von Hippel-Lindau Treatment Introduction
11.4.4 Astellas US Holding, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.4.5 Astellas US Holding, Inc. Recent Development
11.5 Advantagene, Inc
11.5.1 Advantagene, Inc Company Details
11.5.2 Advantagene, Inc Business Overview
11.5.3 Advantagene, Inc Von Hippel-Lindau Treatment Introduction
11.5.4 Advantagene, Inc Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.5.5 Advantagene, Inc Recent Development
11.6 Burzynski Research Institute, Inc.
11.6.1 Burzynski Research Institute, Inc. Company Details
11.6.2 Burzynski Research Institute, Inc. Business Overview
11.6.3 Burzynski Research Institute, Inc. Von Hippel-Lindau Treatment Introduction
11.6.4 Burzynski Research Institute, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.6.5 Burzynski Research Institute, Inc. Recent Development
11.7 Cellectar Biosciences, Inc.
11.7.1 Cellectar Biosciences, Inc. Company Details
11.7.2 Cellectar Biosciences, Inc. Business Overview
11.7.3 Cellectar Biosciences, Inc. Von Hippel-Lindau Treatment Introduction
11.7.4 Cellectar Biosciences, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.7.5 Cellectar Biosciences, Inc. Recent Development
11.8 Direct Therapeutics, Inc.
11.8.1 Direct Therapeutics, Inc. Company Details
11.8.2 Direct Therapeutics, Inc. Business Overview
11.8.3 Direct Therapeutics, Inc. Von Hippel-Lindau Treatment Introduction
11.8.4 Direct Therapeutics, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021)
11.8.5 Direct Therapeutics, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Von Hippel-Lindau Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MRI Scan
Table 3. Key Players of CT Scan
Table 4. Key Players of Others
Table 5. Global Von Hippel-Lindau Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Von Hippel-Lindau Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Von Hippel-Lindau Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Von Hippel-Lindau Treatment Market Share by Regions (2016-2021)
Table 9. Global Von Hippel-Lindau Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Von Hippel-Lindau Treatment Market Share by Regions (2022-2027)
Table 11. Von Hippel-Lindau Treatment Market Trends
Table 12. Von Hippel-Lindau Treatment Market Drivers
Table 13. Von Hippel-Lindau Treatment Market Challenges
Table 14. Von Hippel-Lindau Treatment Market Restraints
Table 15. Global Von Hippel-Lindau Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Von Hippel-Lindau Treatment Market Share by Players (2016-2021)
Table 17. Global Top Von Hippel-Lindau Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Von Hippel-Lindau Treatment as of 2020)
Table 18. Ranking of Global Top Von Hippel-Lindau Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Von Hippel-Lindau Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Von Hippel-Lindau Treatment Product Solution and Service
Table 22. Date of Enter into Von Hippel-Lindau Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Von Hippel-Lindau Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Von Hippel-Lindau Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Von Hippel-Lindau Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Von Hippel-Lindau Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Von Hippel-Lindau Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Von Hippel-Lindau Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Von Hippel-Lindau Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Von Hippel-Lindau Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Von Hippel-Lindau Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Von Hippel-Lindau Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Von Hippel-Lindau Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Von Hippel-Lindau Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Von Hippel-Lindau Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Von Hippel-Lindau Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Von Hippel-Lindau Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Von Hippel-Lindau Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Von Hippel-Lindau Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Von Hippel-Lindau Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Von Hippel-Lindau Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Von Hippel-Lindau Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Von Hippel-Lindau Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Von Hippel-Lindau Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Von Hippel-Lindau Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Von Hippel-Lindau Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly and Company Company Details
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Von Hippel-Lindau Treatment Product
Table 65. Eli Lilly and Company Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. Bedford Laboratories Company Details
Table 68. Bedford Laboratories Business Overview
Table 69. Bedford Laboratories Von Hippel-Lindau Treatment Product
Table 70. Bedford Laboratories Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 71. Bedford Laboratories Recent Development
Table 72. DNAtrix, Inc. Company Details
Table 73. DNAtrix, Inc. Business Overview
Table 74. DNAtrix, Inc. Von Hippel-Lindau Treatment Product
Table 75. DNAtrix, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 76. DNAtrix, Inc. Recent Development
Table 77. Astellas US Holding, Inc. Company Details
Table 78. Astellas US Holding, Inc. Business Overview
Table 79. Astellas US Holding, Inc. Von Hippel-Lindau Treatment Product
Table 80. Astellas US Holding, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 81. Astellas US Holding, Inc. Recent Development
Table 82. Advantagene, Inc Company Details
Table 83. Advantagene, Inc Business Overview
Table 84. Advantagene, Inc Von Hippel-Lindau Treatment Product
Table 85. Advantagene, Inc Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 86. Advantagene, Inc Recent Development
Table 87. Burzynski Research Institute, Inc. Company Details
Table 88. Burzynski Research Institute, Inc. Business Overview
Table 89. Burzynski Research Institute, Inc. Von Hippel-Lindau Treatment Product
Table 90. Burzynski Research Institute, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 91. Burzynski Research Institute, Inc. Recent Development
Table 92. Cellectar Biosciences, Inc. Company Details
Table 93. Cellectar Biosciences, Inc. Business Overview
Table 94. Cellectar Biosciences, Inc. Von Hippel-Lindau Treatment Product
Table 95. Cellectar Biosciences, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 96. Cellectar Biosciences, Inc. Recent Development
Table 97. Direct Therapeutics, Inc. Company Details
Table 98. Direct Therapeutics, Inc. Business Overview
Table 99. Direct Therapeutics, Inc. Revenue in Von Hippel-Lindau Treatment Business (2016-2021) & (US$ Million)
Table 100. Direct Therapeutics, Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Von Hippel-Lindau Treatment Market Share by Type: 2020 VS 2027
Figure 2. MRI Scan Features
Figure 3. CT Scan Features
Figure 4. Others Features
Figure 5. Global Von Hippel-Lindau Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Von Hippel-Lindau Treatment Report Years Considered
Figure 11. Global Von Hippel-Lindau Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Von Hippel-Lindau Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Von Hippel-Lindau Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Von Hippel-Lindau Treatment Market Share by Regions (2022-2027)
Figure 15. Global Von Hippel-Lindau Treatment Market Share by Players in 2020
Figure 16. Global Top Von Hippel-Lindau Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Von Hippel-Lindau Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Von Hippel-Lindau Treatment Revenue in 2020
Figure 18. Global Von Hippel-Lindau Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Von Hippel-Lindau Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Von Hippel-Lindau Treatment Market Share by Type (2016-2027)
Figure 22. North America Von Hippel-Lindau Treatment Market Share by Application (2016-2027)
Figure 23. North America Von Hippel-Lindau Treatment Market Share by Country (2016-2027)
Figure 24. United States Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Von Hippel-Lindau Treatment Market Share by Type (2016-2027)
Figure 28. Europe Von Hippel-Lindau Treatment Market Share by Application (2016-2027)
Figure 29. Europe Von Hippel-Lindau Treatment Market Share by Country (2016-2027)
Figure 30. Germany Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Von Hippel-Lindau Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Von Hippel-Lindau Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Von Hippel-Lindau Treatment Market Share by Region (2016-2027)
Figure 40. China Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Von Hippel-Lindau Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Von Hippel-Lindau Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Von Hippel-Lindau Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Von Hippel-Lindau Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Von Hippel-Lindau Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Von Hippel-Lindau Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Von Hippel-Lindau Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 60. Bedford Laboratories Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 61. DNAtrix, Inc. Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 62. Astellas US Holding, Inc. Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 63. Advantagene, Inc Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 64. Burzynski Research Institute, Inc. Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 65. Cellectar Biosciences, Inc. Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 66. Direct Therapeutics, Inc. Revenue Growth Rate in Von Hippel-Lindau Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---